MedPath

Resistance Training impact on lean mass and Muscle Strength in Pancreatic Cancer

Phase 4
Completed
Conditions
Cancer
Musculoskeletal Diseases
Registration Number
PACTR202001818109834
Lead Sponsor
FATMA ALZAHRAA H. KAME
Brief Summary

A relative short duration of resistant exercises improved considerably lean body mass, muscle strength and functional performance in pancreatic cancer cachexia. The exercise regimen has been well tolerated and should be strongly suggested for these patients as an important support measure to counteract cachexia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

resectable or non-resectable PC [stages I–IV].
adults [= 20 years of age].
compliance with international guidelines for cancer cachexia diagnosis, including:
weight loss over the past 6 months > 5 percent.
weight loss > 2 percent in patients with body mass index [BMI] of less than 20 kg / m2,
evidence of sarcopenia with a weight loss of more than 2 percent.

Exclusion Criteria

any musculoskeletal disorders
any neurological disorders
the hematological capacity was severely impaired,
uncontrolled hypertension,
heart failure and unknown arrhythmia,
severe renal impairment,
diminished ability to stand or walk,
any other comorbidities that may hinder exercise.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.